Prolacta honors and values breastfeeding mothers and their committment to the health of babies
Clinically proven to improve health outcomes of critically ill preemies
Committed to scientific and clinical research in breast milk
Prolact Product Safety

The National Coalition for Infant Health released a new web video, “Why Preemies Need Access to an Exclusive Human Milk Diet.” The video explains how a diet of only human milk and human milk-derived products helps preemies by boosting their immune systems, reducing respiratory complications, and preventing GI infections. It also outlines the barriers that preemies and their mothers face in accessing an exclusive human milk diet.


Why Choose Prolacta?

We are making the difference in the lives of premature infants.

Prolacta Bioscience, Inc. (Prolacta) is the pioneer in standardized human milk-based nutritional products for premature infants in the neonatal intensive care unit (NICU). Prolacta believes that there is no adequate replacement for human breast milk and, as such, we believe infant nutritional products should be human milk-based. As a privately held, for-profit and scientifically driven company, committed to improving premature infant nutrition, we are using human milk to change the standard of care in the NICU. Mothers who have a surplus of breast milk can help save the country’s most fragile infants by donating their extra breast milk through one of Prolacta’s affiliate milk banks.

Join us for the next webinar to review the article

Follow Us!